Join Now

Recent BioUtah News & Events

Everything Happening in Utah Life Sciences

February 17, 2022
BioUtah News
The BioHive Descends on Capitol Hill

Life Sciences Day on Capitol Hill was held on February 16 filling the Capitol rotunda with 24 companies showcasing their innovations to lawmakers and collectively, reflecting the strength of Utah’s BioHive. Lt. Governor Deidre Henderson was on hand to personally visit with company representatives and learn about the important work they’re doing to advance healthcare. […]

February 17, 2022
BioUtah News
Transit Scientific’s New Scoring Sheath Delivers Low Pressure Angioplasty Treatment in Calcified Arteries

First-of-its kind metal-alloy angioplasty scoring sheath effective in treatment of critical arterial stenosis

February 17, 2022
BioUtah News
ARUP Researchers’ Prolific Publications, Presentations Helped Advance Lab Medicine in 2021

Researchers at ARUP Laboratories made significant contributions to the advancement of laboratory medicine in 2021 as coauthors of more than 150 peer-reviewed articles in academic journals, medical guideline updates, and book chapters. They also contributed more than 40 posters or presentations at national and international medical conferences. Links to each of the 2021 publications and […]

February 17, 2022
BioUtah News
PolarityTE Announces Allowance of Fourth U.S. Patent

PolarityTE, Inc. announced the U.S. Patent and Trademark Office (USPTO) recently issued a Notice of Allowance for U.S. Application No. 17/326,734 filed on May 21, 2021.

February 17, 2022
BioUtah News
ARUP Laboratories Is Ranked Among America’s Best Midsize Employers by Forbes

ARUP’s commitment to creating a satisfying work environment for employees has earned it a spot on Forbes’ list of America’s Best Midsize Employers for 2022.

February 17, 2022
BioUtah News
Nexus Spine Appoints Steve Cichy as Vice President of Sales

Appointment further expands leadership team to support aggressive commercialization of the company’s PressON™ fixation, Tranquil™ interbody, and pending technologies

February 16, 2022
BioUtah News
Epitel Secures $12.5 Million Series A Financing for Wearable, Wireless EEG Monitoring System

FDA-Cleared REMI Platform to Begin Initial Commercialization to Hospitals for Use in Emergency Departments and Intensive Care Units Across the United States

February 10, 2022
BioUtah News
IONIQ Sciences 2021 Year-End Update

Originally published by IONIQ Sciences Dear IONIQ Sciences Shareholders and Friends, Greetings from IONIQ Sciences where we continue to follow the science and invest in exceptional team members, advisors and consultants to help us modernize early-stage cancer detection.  LUNG Cancer – we have submitted our application to the FDA!! We have formally submitted our De Novo application to […]

February 10, 2022
BioUtah News
Stanford Researchers cite BioPharm Laboratories High Purity Thrombin

BioPharm Laboratories, another journal article from the Journal of Biological Chemistry cites the use of BioPharm’s High Purity Thrombin being used to cleave protein in their protein purification process.

February 10, 2022
BioUtah News
Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Hepatitis B Viral Load Test

SALT LAKE CITY, Feb. 3, 2022 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that CoSara Diagnostics Pvt Ltd (“CoSara,” or the “JV”), its joint venture for manufacturing and sales in India, has received clearance by the Central […]

February 10, 2022
BioUtah News
Co-Diagnostics, Inc. to Host Booth at Life Sciences Day on the Hill on February 16 at the Utah State Capital

Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced that it will be hosting a booth at the upcoming Life Sciences Day on the Hill on February 16, 2022, at the Utah State Capital Building. It is expected that the conference, […]

February 10, 2022
BioUtah News
Nelson Labs Launches Verification Program to Help Consumers Identify Properly Tested Masks and Respirators

New Nelson Labs Mark offers transparency and confidence in product testing

February 3, 2022
BioUtah News
IONIQ Sciences submits De Novo application to FDA for IONIQ ProLung Test

Salt Lake City, UT, February 2, 2022 – IONIQ Sciences, Inc. (“IONIQ” or the “Company”) announced today that it has filed a De Novo application with the U.S. Food and Drug Administration (the “FDA”) for its IONIQ ProLung Test™ used for lung cancer. Mr. Jared Bauer, IONIQ Sciences CEO, stated, “Today we submitted our De […]

February 2, 2022
BioUtah News
Fluidx Medical’s Embolic Demonstrates Novel Visibility Advantage

Fluidx Medical Reports Initial Research on First-of-its-Kind Embolic Agent with Intermediate Radiopacity

January 27, 2022
BioUtah News
Biomerics Announces Expansion in Costa Rica With New Plant in Cartago

Biomerics inaugurated its second plant in Costa Rica.

January 20, 2022
BioUtah News
GPX Embolic Device Success in Challenging Tumor Case

Fluidx Medical’s Novel Embolic Device Demonstrates Repeated Success in Treating Complex Tumors

January 19, 2022
BioUtah News
Foldax Appoints Scott Huennekens to Board of Directors

Foldax Appoints Scott Huennekens to Board of Directors

January 19, 2022
BioUtah News
PolarityTE Announces U.S. FDA Approval of IND for Pivotal Phase 3 Study of SkinTE® to Support Chronic Cutaneous Ulcer Indication

PolarityTE, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved its investigational new drug (IND) application for the evaluation of SkinTE for the treatment of chronic cutaneous ulcers.

January 13, 2022
BioUtah News
Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for High-Risk HPV Multiplex Test

Co-Diagnostics, Inc. announced that CoSara Diagnostics Pvt Ltd has received clearance by the Central Drugs Standard Control Organization (“CDSCO”) in India to manufacture and sell its SARAGENE™ Human Papillomavirus High-Risk (HPV-HR) Real-Time PCR test as an in vitro diagnostic (“IVD”)

January 12, 2022
BioUtah News
New Peripheral Vascular Microcatheters Save Procedure Time and Advance Treatment Capabilities

New Peripheral Vascular Microcatheters Save Procedure Time and Advance Treatment Capabilities

January 11, 2022
BioUtah News
Positive Study Results Published for KidneyIntelXTM in Monitoring Patient Response to New Drug Therapy

Positive Study Results Published for KidneyIntelXTM in Monitoring Patient Response to New Drug Therapy

January 11, 2022
BioUtah News
CenExel Clinical Research Acquires Rocky Mountain Movement Disorders Center

Premier Neurology Facility in Colorado Joins the CenExel Centers of Excellence

January 11, 2022
BioUtah News
CenExel Clinical Research Acquires California Neuroscience Research

CenExel Clinical Research, Inc. announced the acquisition of California Neuroscience Research.

January 11, 2022
BioUtah News
Nexus Spine Appoints David Ivanko as Vice President of Quality Engineering and Manufacturing and Andrew Shepherd as Vice President of Marketing

Nexus Spine announced key appointments to its leadership team that includes David Ivanko as Vice President of Quality Engineering and Manufacturing and Andrew Shepherd as Vice President of Marketing.

January 11, 2022
BioUtah News
Singing River Health System and Renalytix Join Forces to Improve Kidney Health on the Mississippi Gulf Coast

Seventh KidneyIntelX implementation partnership for Renalytix focused on underserved populations with high disease burden

January 6, 2022
Policy News
Transition Plan for Medical Devices Issued FDA EUAs

To help fight the pandemic, the FDA has been issuing EUAs and exercising enforcement discretion for medical devices needed to diagnose, treat, or prevent COVID-19. Last month, the agency issued two draft guidances related to transition plans to regular compliance for COVID-19 related medical devices that fall under EUAs or Agency Enforcement Policies that have […]

January 6, 2022
BioUtah News
BlueWind Medical™ Ltd. Makes Key Additions to Leadership Team

PARK CITY, Utah and HERZLIYA, Israel, Jan. 6, 2022 /PRNewswire/ — BlueWind Medical™, Ltd., developer of the innovative RENOVA™ iStim implantable neuromodulation device for treatment of Overactive Bladder, today announced additions to its leadership team in preparation for commercialization of the RENOVA product line. The company has added Mike Ruger as Vice President of Sales, Sandra […]

January 5, 2022
BioUtah News
American Diabetes Association and Renalytix Partner to Prioritize Kidney Health in Type 2 Diabetes Population

National program establishes early care management, technology innovation and large health system engagement as a strategic priority for supporting the 34 million U.S. individuals living with diabetes

December 27, 2021
BioUtah News
December 22, 2021
BioUtah News
Co-Diagnostics, Inc. Signs Agreement to Acquire all Assets and Intellectual Property Related to At-Home/Point-of-Care Platform

Definitive merger agreements provide the Company with all existing and future assets, future product iterations, and intellectual property rights of the platform, creating a fully integrated product line and streamlining commercialization

December 22, 2021
Policy News
Salt Lake Tribune Features IONIQ Sciences Breast Cancer Screening Technology

In a sign that our BioHive is truly buzzing, the Salt Lake Tribune, recently ran an article on advances in breast cancer detection, highlighting the innovative breast cancer screening technology being developed by IONIQ Sciences. The article notes that IONIQ has teamed up with IONIQ scientific advisor and University of Utah assistant professor, Dr. Benjamin […]

December 21, 2021
BioUtah News
First Clinical Study on TRIA Biopolymer Heart Valve Shows Excellent One-Year Performance

Publication in Journal of the American College of Cardiology (JACC): Cardiovascular Interventions Found TRIA Aortic Heart Valve Provided Sustained Improvement in Heart Valve Function to One-Year with Good Safety Profile